Kansas University and the Mayo Clinic cancer centers are working together on a trial drug that could prevent cancer.

With funding from the National Cancer Institute, the joint research grant focuses on a drug designed from a naturally occurring, anti-cancer agent found in vegetables such as broccoli, cauliflower and cabbage, according to a KU Medical Center news release.

Several formulations of the drug will be developed at KU, under the direction of Roger Rajewski, who is director of the Product Development Core for KU’s Higuchi Biosciences Center. The drugs will then be tested in clinical trials at the Mayo Clinic in Rochester, Minn.

The grant is for $254,500, with nearly $70,000 going toward Rajewski’s research.

The studies conducted under the grant will use healthy volunteers to determine how different formulas of the drug are absorbed, distributed and metabolized in the body.